BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21925739)

  • 1. RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.
    Rao JS; Kellom M; Reese EA; Rapoport SI; Kim HW
    J Affect Disord; 2012 Jan; 136(1-2):63-71. PubMed ID: 21925739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients.
    Rao JS; Kim HW; Harry GJ; Rapoport SI; Reese EA
    Schizophr Res; 2013 Jun; 147(1):24-31. PubMed ID: 23566496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RETRACTED: Chronic administration of carbamazepine down-regulates AP-2 DNA-binding activity and AP-2alpha protein expression in rat frontal cortex.
    Rao JS; Bazinet RP; Rapoport SI; Lee HJ
    Biol Psychiatry; 2007 Jan; 61(2):154-61. PubMed ID: 16806101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction.
    J Neurochem; 2017 Mar; 140(6):979. PubMed ID: 28261876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction.
    J Neurochem; 2017 Mar; 140(6):980. PubMed ID: 28261875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
    Galińska-Skok B; Małus A; Konarzewska B; Rogowska-Zach A; Milewski R; Tarasów E; Szulc A; Waszkiewicz N
    Dis Markers; 2018; 2018():3654894. PubMed ID: 30595760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder.
    McCullumsmith RE; Meador-Woodruff JH
    Neuropsychopharmacology; 2002 Mar; 26(3):368-75. PubMed ID: 11850151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.
    Bauer D; Gupta D; Harotunian V; Meador-Woodruff JH; McCullumsmith RE
    Schizophr Res; 2008 Sep; 104(1-3):108-20. PubMed ID: 18678470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder.
    Hamazaki K; Maekawa M; Toyota T; Dean B; Hamazaki T; Yoshikawa T
    Psychiatry Res; 2015 Jun; 227(2-3):353-9. PubMed ID: 25858798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine-induced reduction of glutamate transport in the frontal cortex is not mediated by GLAST and EAAC1.
    Melone M; Bragina L; Conti F
    Mol Psychiatry; 2003 Jan; 8(1):12-3. PubMed ID: 12556903
    [No Abstract]   [Full Text] [Related]  

  • 11. N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study.
    Nudmamud S; Reynolds LM; Reynolds GP
    Biol Psychiatry; 2003 Jun; 53(12):1138-41. PubMed ID: 12814865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA, glutamate, dopamine and serotonin transporters expression on memory formation and amnesia.
    Tellez R; Gómez-Víquez L; Meneses A
    Neurobiol Learn Mem; 2012 Feb; 97(2):189-201. PubMed ID: 22183017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RETRACTED: Placental serotonin systems in pregnancy metabolic complications associated with maternal obesity and gestational diabetes mellitus.
    Murthi P; Vaillancourt C
    Biochim Biophys Acta Mol Basis Dis; 2020 Feb; 1866(2):165391. PubMed ID: 30738809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium.
    Johnston-Wilson NL; Sims CD; Hofmann JP; Anderson L; Shore AD; Torrey EF; Yolken RH
    Mol Psychiatry; 2000 Mar; 5(2):142-9. PubMed ID: 10822341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the dopamine transporter-dopamine D2 receptor interaction in schizophrenia.
    Lee FJ; Pei L; Liu F
    Synapse; 2009 Aug; 63(8):710-2. PubMed ID: 19391151
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of glutamate transporters and ionotropic glutamate receptors in GLAST knockout mice.
    Ueda Y; Doi T; Tsuru N; Tokumaru J; Mitsuyama Y
    Brain Res Mol Brain Res; 2002 Aug; 104(2):120-6. PubMed ID: 12225864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scyllo-inositol in post-mortem brain of bipolar, unipolar and schizophrenic patients.
    Shapiro J; Belmaker RH; Biegon A; Seker A; Agam G
    J Neural Transm (Vienna); 2000; 107(5):603-7. PubMed ID: 11072754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder.
    Sabunciyan S; Kirches E; Krause G; Bogerts B; Mawrin C; Llenos IC; Weis S
    J Neural Transm (Vienna); 2007; 114(5):665-74. PubMed ID: 17195919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for altered cell membrane lipid composition in postmortem prefrontal white matter in bipolar disorder and schizophrenia.
    Ghosh S; Dyer RA; Beasley CL
    J Psychiatr Res; 2017 Dec; 95():135-142. PubMed ID: 28843843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA
    Fatemi SH; Folsom TD; Thuras PD
    Synapse; 2017 Jul; 71(7):. PubMed ID: 28316115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.